| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8312007 | Clinica Chimica Acta | 2014 | 6 Pages |
Abstract
A dose effect between the CK-18 concentration and the severity of NAFLD was found in the T2DM patients; thus, the CK-18 concentration is a potentially useful biomarker for assessing the efficacy of treatment and the improvement in NAFLD in patients with T2DM.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Mai Miyasato, Yuko Murase-Mishiba, Megumi Bessho, Masahiro Miyawaki, Hisashi Imbe, Chiharu Tsutsumi, Keiji Tanimoto, Akihisa Imagawa, Jungo Terasaki, Toshiaki Hanafusa,